Global Mobile Molecular Diagnostic System Market Research Report 2025

Publication ID:

PB505255872

Publication Date:

May 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Mobile Molecular Diagnostic System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mobile Molecular Diagnostic System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mobile Molecular Diagnostic System.
The Mobile Molecular Diagnostic System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mobile Molecular Diagnostic System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mobile Molecular Diagnostic System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Thermo Fisher
Thrive Bioscience
Roche
Sansure Biotech
OriginGene-tech Biotechnology
Baicare
CapitalBio
houzeBio
Tianlong
Easy Diagnosis Biomedicine
Segment by Type
Single Channel
Four Channels
Segment by Application
Hospital
Research
Disease Control Department
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mobile Molecular Diagnostic System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mobile Molecular Diagnostic System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Mobile Molecular Diagnostic System Market Overview
1.1 Product Definition
1.2 Mobile Molecular Diagnostic System by Type
1.2.1 Global Mobile Molecular Diagnostic System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single Channel
1.2.3 Four Channels
1.3 Mobile Molecular Diagnostic System by Application
1.3.1 Global Mobile Molecular Diagnostic System Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Research
1.3.4 Disease Control Department
1.3.5 Other
1.4 Global Mobile Molecular Diagnostic System Market Size Estimates and Forecasts
1.4.1 Global Mobile Molecular Diagnostic System Revenue 2020-2031
1.4.2 Global Mobile Molecular Diagnostic System Sales 2020-2031
1.4.3 Global Mobile Molecular Diagnostic System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mobile Molecular Diagnostic System Market Competition by Manufacturers
2.1 Global Mobile Molecular Diagnostic System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mobile Molecular Diagnostic System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mobile Molecular Diagnostic System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mobile Molecular Diagnostic System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mobile Molecular Diagnostic System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mobile Molecular Diagnostic System, Product Type & Application
2.7 Global Key Manufacturers of Mobile Molecular Diagnostic System, Date of Enter into This Industry
2.8 Global Mobile Molecular Diagnostic System Market Competitive Situation and Trends
2.8.1 Global Mobile Molecular Diagnostic System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mobile Molecular Diagnostic System Players Market Share by Revenue
2.8.3 Global Mobile Molecular Diagnostic System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mobile Molecular Diagnostic System Market Scenario by Region
3.1 Global Mobile Molecular Diagnostic System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mobile Molecular Diagnostic System Sales by Region: 2020-2031
3.2.1 Global Mobile Molecular Diagnostic System Sales by Region: 2020-2025
3.2.2 Global Mobile Molecular Diagnostic System Sales by Region: 2026-2031
3.3 Global Mobile Molecular Diagnostic System Revenue by Region: 2020-2031
3.3.1 Global Mobile Molecular Diagnostic System Revenue by Region: 2020-2025
3.3.2 Global Mobile Molecular Diagnostic System Revenue by Region: 2026-2031
3.4 North America Mobile Molecular Diagnostic System Market Facts & Figures by Country
3.4.1 North America Mobile Molecular Diagnostic System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mobile Molecular Diagnostic System Sales by Country (2020-2031)
3.4.3 North America Mobile Molecular Diagnostic System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mobile Molecular Diagnostic System Market Facts & Figures by Country
3.5.1 Europe Mobile Molecular Diagnostic System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mobile Molecular Diagnostic System Sales by Country (2020-2031)
3.5.3 Europe Mobile Molecular Diagnostic System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mobile Molecular Diagnostic System Market Facts & Figures by Region
3.6.1 Asia Pacific Mobile Molecular Diagnostic System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mobile Molecular Diagnostic System Sales by Region (2020-2031)
3.6.3 Asia Pacific Mobile Molecular Diagnostic System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mobile Molecular Diagnostic System Market Facts & Figures by Country
3.7.1 Latin America Mobile Molecular Diagnostic System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mobile Molecular Diagnostic System Sales by Country (2020-2031)
3.7.3 Latin America Mobile Molecular Diagnostic System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mobile Molecular Diagnostic System Market Facts & Figures by Country
3.8.1 Middle East and Africa Mobile Molecular Diagnostic System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mobile Molecular Diagnostic System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mobile Molecular Diagnostic System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mobile Molecular Diagnostic System Sales by Type (2020-2031)
4.1.1 Global Mobile Molecular Diagnostic System Sales by Type (2020-2025)
4.1.2 Global Mobile Molecular Diagnostic System Sales by Type (2026-2031)
4.1.3 Global Mobile Molecular Diagnostic System Sales Market Share by Type (2020-2031)
4.2 Global Mobile Molecular Diagnostic System Revenue by Type (2020-2031)
4.2.1 Global Mobile Molecular Diagnostic System Revenue by Type (2020-2025)
4.2.2 Global Mobile Molecular Diagnostic System Revenue by Type (2026-2031)
4.2.3 Global Mobile Molecular Diagnostic System Revenue Market Share by Type (2020-2031)
4.3 Global Mobile Molecular Diagnostic System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mobile Molecular Diagnostic System Sales by Application (2020-2031)
5.1.1 Global Mobile Molecular Diagnostic System Sales by Application (2020-2025)
5.1.2 Global Mobile Molecular Diagnostic System Sales by Application (2026-2031)
5.1.3 Global Mobile Molecular Diagnostic System Sales Market Share by Application (2020-2031)
5.2 Global Mobile Molecular Diagnostic System Revenue by Application (2020-2031)
5.2.1 Global Mobile Molecular Diagnostic System Revenue by Application (2020-2025)
5.2.2 Global Mobile Molecular Diagnostic System Revenue by Application (2026-2031)
5.2.3 Global Mobile Molecular Diagnostic System Revenue Market Share by Application (2020-2031)
5.3 Global Mobile Molecular Diagnostic System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Mobile Molecular Diagnostic System Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Thrive Bioscience
6.2.1 Thrive Bioscience Company Information
6.2.2 Thrive Bioscience Description and Business Overview
6.2.3 Thrive Bioscience Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thrive Bioscience Mobile Molecular Diagnostic System Product Portfolio
6.2.5 Thrive Bioscience Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Mobile Molecular Diagnostic System Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Sansure Biotech
6.4.1 Sansure Biotech Company Information
6.4.2 Sansure Biotech Description and Business Overview
6.4.3 Sansure Biotech Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sansure Biotech Mobile Molecular Diagnostic System Product Portfolio
6.4.5 Sansure Biotech Recent Developments/Updates
6.5 OriginGene-tech Biotechnology
6.5.1 OriginGene-tech Biotechnology Company Information
6.5.2 OriginGene-tech Biotechnology Description and Business Overview
6.5.3 OriginGene-tech Biotechnology Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 OriginGene-tech Biotechnology Mobile Molecular Diagnostic System Product Portfolio
6.5.5 OriginGene-tech Biotechnology Recent Developments/Updates
6.6 Baicare
6.6.1 Baicare Company Information
6.6.2 Baicare Description and Business Overview
6.6.3 Baicare Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Baicare Mobile Molecular Diagnostic System Product Portfolio
6.6.5 Baicare Recent Developments/Updates
6.7 CapitalBio
6.7.1 CapitalBio Company Information
6.7.2 CapitalBio Description and Business Overview
6.7.3 CapitalBio Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CapitalBio Mobile Molecular Diagnostic System Product Portfolio
6.7.5 CapitalBio Recent Developments/Updates
6.8 houzeBio
6.8.1 houzeBio Company Information
6.8.2 houzeBio Description and Business Overview
6.8.3 houzeBio Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 houzeBio Mobile Molecular Diagnostic System Product Portfolio
6.8.5 houzeBio Recent Developments/Updates
6.9 Tianlong
6.9.1 Tianlong Company Information
6.9.2 Tianlong Description and Business Overview
6.9.3 Tianlong Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Tianlong Mobile Molecular Diagnostic System Product Portfolio
6.9.5 Tianlong Recent Developments/Updates
6.10 Easy Diagnosis Biomedicine
6.10.1 Easy Diagnosis Biomedicine Company Information
6.10.2 Easy Diagnosis Biomedicine Description and Business Overview
6.10.3 Easy Diagnosis Biomedicine Mobile Molecular Diagnostic System Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Easy Diagnosis Biomedicine Mobile Molecular Diagnostic System Product Portfolio
6.10.5 Easy Diagnosis Biomedicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mobile Molecular Diagnostic System Industry Chain Analysis
7.2 Mobile Molecular Diagnostic System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mobile Molecular Diagnostic System Production Mode & Process Analysis
7.4 Mobile Molecular Diagnostic System Sales and Marketing
7.4.1 Mobile Molecular Diagnostic System Sales Channels
7.4.2 Mobile Molecular Diagnostic System Distributors
7.5 Mobile Molecular Diagnostic System Customer Analysis
8 Mobile Molecular Diagnostic System Market Dynamics
8.1 Mobile Molecular Diagnostic System Industry Trends
8.2 Mobile Molecular Diagnostic System Market Drivers
8.3 Mobile Molecular Diagnostic System Market Challenges
8.4 Mobile Molecular Diagnostic System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Thermo Fisher
Thrive Bioscience
Roche
Sansure Biotech
OriginGene-tech Biotechnology
Baicare
CapitalBio
houzeBio
Tianlong
Easy Diagnosis Biomedicine

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂